本页面由Tiger Trade Technology Pte. Ltd.提供服务

Estrella Immunopharma

1.05
+0.01000.96%
盘后1.050.00000.00%17:18 EDT
成交量:3.93万
成交额:4.09万
市值:4,479.85万
市盈率:-2.96
高:1.07
开:1.01
低:1.01
收:1.04
52周最高:3.15
52周最低:0.7301
股本:4,266.52万
流通股本:1,802.15万
量比:0.42
换手率:0.22%
股息:- -
股息率:- -
每股收益(TTM):-0.3548
每股收益(LYR):-0.3548
净资产收益率:-268.50%
总资产收益率:-258.45%
市净率:-4.32
市盈率(LYR):-2.96

数据加载中...

2024/02/02

重要事件披露

Form 8-K - Current report
2024/01/31

重要事件披露

Form 8-K - Current report
2023/12/28

SEC问询函

Form CORRESP - Correspondence
2023/12/18

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/12/16

SEC问询函

Form CORRESP - Correspondence
2023/11/21

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/14

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/11/14

SEC问询函

Form CORRESP - Correspondence
2023/11/13

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/10/30

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/10/11

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/10/05

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/10/05

重要事件披露

Form 8-K - Current report
2023/09/20

重要事件披露

Form 8-K - Current report
2023/09/20

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/09/18

重要事件披露

Form 8-K - Current report
2023/09/18

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/08/18

重要事件披露

Form 8-K - Current report
2023/08/18

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/08/01

重要事件披露

Form 8-K - Current report